Dan King, MS, EMBA, BSBEDan King, MS, EMBA, BSBE• 2nd• 2ndArea Business Manager | Outcome Driven | People Focused | Passi
It is exciting to go beyond just closing wounds and offer true building blocks to surgeons. PolyNovo continues to disrupt the space across the world with our laser focus on patient outcomes, clinical efficiency, and healthcare costs. The start of a platform is here and being utilized for effect!
https://www.linkedin.com/feed/update/urn:li:activity:7232775007716679682/
PolyNovo Limited
Dr. Phu C. Tran demonstrates his initial use of NovoSorb® MTX at Medical City Plano, TX. His surgical treatment approach for a large anterior chest Hurley stage 3 Hidradenitis Suppurativa involves a two-stage reconstruction with NovoSorb MTX first applied to the deep center and NovoSorb BTM applied over the top as a protective cover. Read the full report here:https://l.ead.me/bfIriJ
Dan King, MS, EMBA, BSBEDan King, MS, EMBA, BSBE• 2nd• 2ndArea...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
-0.040(1.94%) |
Mkt cap ! $1.395B | |||
| Open | High | Low | Value | Volume |
| $2.01 | $2.04 | $2.00 | $1.537M | 762.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41008 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 5942 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |